1. Home
  2. SPOK vs RCEL Comparison

SPOK vs RCEL Comparison

Compare SPOK & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPOK
  • RCEL
  • Stock Information
  • Founded
  • SPOK 2004
  • RCEL N/A
  • Country
  • SPOK United States
  • RCEL United States
  • Employees
  • SPOK N/A
  • RCEL N/A
  • Industry
  • SPOK Telecommunications Equipment
  • RCEL Medical/Dental Instruments
  • Sector
  • SPOK Telecommunications
  • RCEL Health Care
  • Exchange
  • SPOK Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • SPOK 318.9M
  • RCEL 161.5M
  • IPO Year
  • SPOK 1992
  • RCEL N/A
  • Fundamental
  • Price
  • SPOK $17.55
  • RCEL $5.35
  • Analyst Decision
  • SPOK Hold
  • RCEL Strong Buy
  • Analyst Count
  • SPOK 1
  • RCEL 4
  • Target Price
  • SPOK $15.00
  • RCEL $16.50
  • AVG Volume (30 Days)
  • SPOK 102.6K
  • RCEL 326.4K
  • Earning Date
  • SPOK 07-23-2025
  • RCEL 08-07-2025
  • Dividend Yield
  • SPOK 7.07%
  • RCEL N/A
  • EPS Growth
  • SPOK N/A
  • RCEL N/A
  • EPS
  • SPOK 0.77
  • RCEL N/A
  • Revenue
  • SPOK $139,038,000.00
  • RCEL $71,661,000.00
  • Revenue This Year
  • SPOK $2.26
  • RCEL $57.16
  • Revenue Next Year
  • SPOK $2.54
  • RCEL $36.69
  • P/E Ratio
  • SPOK $22.95
  • RCEL N/A
  • Revenue Growth
  • SPOK N/A
  • RCEL 41.35
  • 52 Week Low
  • SPOK $13.55
  • RCEL $4.71
  • 52 Week High
  • SPOK $17.96
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • SPOK 70.09
  • RCEL 34.33
  • Support Level
  • SPOK $16.41
  • RCEL $4.71
  • Resistance Level
  • SPOK $17.26
  • RCEL $5.45
  • Average True Range (ATR)
  • SPOK 0.28
  • RCEL 0.33
  • MACD
  • SPOK 0.09
  • RCEL 0.01
  • Stochastic Oscillator
  • SPOK 92.37
  • RCEL 25.31

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: